3 ML Tecvayli 10 MG/ML Injection
- RxCUI
- 2619438
- RxNorm name
- 3 ML Tecvayli 10 MG/ML Injection
- Display name
- 3 ML Tecvayli 10 MG/ML Injection
- Full name
- 3 ML Tecvayli 10 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761291 | Tecvayli | teclistamab-cqyv | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TECVAYLI | TECLISTAMAB-CQYV | Janssen Biotech, Inc. | 54e0f974-ccee-44ea-9254-40e9883cee1e | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 2619438 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 54e0f974-ccee-44ea-9254-40e9883cee1e | 3 ML Tecvayli 10 MG/ML Injection | SY | 16 | These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260310 |
| 54e0f974-ccee-44ea-9254-40e9883cee1e | 3 ML teclistamab-cqyv 10 MG/ML Injection [Tecvayli] | SBD | 16 | These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260310 |
| 54e0f974-ccee-44ea-9254-40e9883cee1e | Tecvayli 30 MG per 3 ML Injection | SY | 16 | These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260310 |
| 54e0f974-ccee-44ea-9254-40e9883cee1e | TECVAYLI 30 MG in 3 ML Injection | PSN | 16 | These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260310 |